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Background
Coronary artery disease (CAD) is a major cardiac disease
in humans. Many CAD patients develop left ventricle
dysfunction (LVD), leading to congestive heart failure.
Mutations in several genes including those encoding
sarcomeric proteins such as MYBPC3, TNNT2, and TTN
are common genetic cause of hereditary cardiac myopa-
thies. An intronic 25-bp deletion in MYBPC3 at 3’ region
is associated with dilated (DCM) and hypertrophic
(HCM) cardiomyopathies in Southeast Asia. We sought
to determine the role of MYBPC3 25bp, TNNT2 5bp and
TNN 18bp ins/del polymorphisms on LVD in CAD
patients.
Methods and results
The study included 200 healthy controls and 988 conse-
cutive patients with angiographically confirmed CAD.
Among them, 253 with reduced ejection fraction (LVEF
<45%) were categorized as having LVD. MYBPC3 25bp,
TNNT2 5bp and TNN 18bp ins/del polymorphisms
were determined by polymerase chain reaction. Our
results showed that MYBPC3 25bp deletion was signifi-
cantly associated with CAD as well as LVD (healthy
controls v/s CAD; p value = 0.003; OR=4.08, healthy
controls v/s LVD; p value < 0.0001; OR=6.67 and Non-
LVD v/s LVD; p value = 0.031; OR=1.67). The TNNT2
5bp and TNN 18bp polymorphisms were not found
to be associated with CAD (Pvalue=0.580, OR=0.88; Pva-
lue=0.795, OR=0.91; respectively) or LVD (Pvalue=0.146,
OR=1.35; Pvalue=0.935, OR=0.97 respectively) when
compared to controls.
Conclusions
The frequency of MYBPC3 DW genotype and D allele
was associated with LVD implying that genetic variants
ofMYBPC3 encoding mutant structural sarcomeric protein
could increase susceptibility to left ventricular dysfunction.
Therefore, 25bp deletion in MYBPC3 may represent a
genetic marker for cardiac failure in CAD patients.
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